Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Triple-Microenvironment Decoding Enables Logic-Unlocked Precision Photoimmunotherapy.

Angewandte Chemie (International ed. in English)·2026
Same author

"Dual-lock"-controlled activatable nanotheranostics for chemiluminescence resonance energy transfer (CRET)-driven enhanced photoimmunotherapy.

Journal of materials chemistry. B·2026
Same author

Dual-quenched and redox-responsive gold nanoplatforms for tumor-specific multimodal theranostics.

Nanoscale·2026
Same author

Cascade-Activatable Nanoprobes for NIR-II Fluorescence/Photoacoustic Dual-Modal Imaging of Atherosclerotic Plaques.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Post-Synthetic Modification of the C═C Linkage in a Vinylene-Linked COF for ROS-Mediated Enamine Dimerization.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

DNA-Targeted Sonodynamic Activation Enhances Antibacterial Efficacy in Deep and Hypoxic Infections.

Journal of the American Chemical Society·2026

Related Experiment Video

Updated: Mar 10, 2026

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination
05:39

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination

Published on: February 9, 2021

3.8K

Immune-Evasive NIR-II Nanoplatforms for Repeatable Photodynamic Therapy.

Qihang Ding1, Mengqi Li2, Ling Mei3

  • 1Department of Chemistry, Korea University, Seoul 02841, Korea.

Journal of the American Chemical Society
|March 9, 2026
PubMed
Summary

This study introduces KD1@HPEG nanoparticles, a novel platform for advanced photodynamic therapy (PDT). These nanoparticles overcome key limitations of traditional PDT, enabling repeatable, precise treatments with reduced immune response.

More Related Videos

Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique
05:18

Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique

Published on: March 14, 2016

8.3K
An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
11:04

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

Published on: January 13, 2023

3.8K

Related Experiment Videos

Last Updated: Mar 10, 2026

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination
05:39

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination

Published on: February 9, 2021

3.8K
Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique
05:18

Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique

Published on: March 14, 2016

8.3K
An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
11:04

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

Published on: January 13, 2023

3.8K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Photochemistry

Background:

  • Photodynamic therapy (PDT) is limited by oxygen dependency, heat generation, and immune clearance during repeated treatments.
  • Existing PDT strategies face challenges in clinical translation due to systemic toxicity and reduced efficacy over time.

Purpose of the Study:

  • To develop a next-generation, immune-evasive photodynamic nanoplatform for sustainable and precise PDT.
  • To engineer a system that overcomes oxygen dependence and minimizes immune clearance for enhanced therapeutic outcomes.

Main Methods:

  • Synthesized KD1-loaded hyaluronic acid-poly(ethylene glycol) nanoparticles (KD1@HPEG NPs) utilizing Type I photochemistry.
  • Incorporated a thiopyrylium photosensitizer (KD1) with specific substituents to enhance intersystem crossing and ROS generation.
  • Engineered stealth surface properties to evade immune clearance and improve tumor targeting.

Main Results:

  • KD1@HPEG NPs demonstrated efficient Type I reactive oxygen species (ROS) generation with negligible heat release.
  • The nanoparticles exhibited oxygen-independent ROS production and sustained near-infrared II (NIR-II) fluorescence imaging.
  • The platform showed preserved therapeutic efficacy under repeated dosing, circumventing accelerated blood clearance.

Conclusions:

  • KD1@HPEG NPs represent a generalizable strategy for long-term, immune-tolerant photodynamic therapy.
  • This nanoplatform offers a clinically viable approach for durable, precision phototheranostics with enhanced safety and efficacy.